SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-130685
Filing Date
2024-05-03
Accepted
2024-05-03 16:05:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d835411d424b5.htm 424B5 402172
2 GRAPHIC g835411g00m50.jpg GRAPHIC 77208
3 GRAPHIC g835411g42p18.jpg GRAPHIC 53230
  Complete submission text file 0001193125-24-130685.txt   579340
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-270921 | Film No.: 24913017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)